Have a personal or library account? Click to login
Invasive FFR — Current Applications and New Developments Cover

Invasive FFR — Current Applications and New Developments

Open Access
|Dec 2016

References

  1. 1. Shaw LJ, Berman DS, Marin DJ, et al. Optimal medical therapy with or without percutaneous coronaru interventions to reduce ischaemic burden: results from the Clinical Outcomes Utilizing Revascularization and aggressive drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283-1291.10.1161/CIRCULATIONAHA.107.743963
  2. 2. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischaemia after myocardial infarction: The SWISS II randomized controlled trial. JAMA. 2007;297:1985-1991.10.1001/jama.297.18.1985
  3. 3. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow up of the DEFER Study. J Am Coll Cardiol. 2007;49:2105-2111.10.1016/j.jacc.2007.01.087
  4. 4. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA. 2008;300:1765-1773.10.1001/jama.300.15.1765
  5. 5. Melikian N, De Bondt P, Tonino P, et al. Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowing of moderate severity. Am J Cardiol. 2002;90:210-215.10.1016/S0002-9149(02)02456-6
  6. 6. Christou MA, Siontis GC, Katristris DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol. 2007;99:450-456.10.1016/j.amjcard.2006.09.09217293182
  7. 7. Tonino PA, de Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213-224.10.1056/NEJMoa080761119144937
  8. 8. Bourdarias JP. Coronary reserve: concept and physiological variations. Eur Heart J. 1995;16(supplI):2-6.10.1093/eurheartj/16.suppl_I.28829952
  9. 9. Jeremias A, Whitbourn RJ, Filardo SD, et al. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J. 2000;140:651-657.10.1067/mhj.2000.10992011011341
  10. 10. Pijls NH, Tonino PA, Fearon WF. Fractional flow reserve for guiding PCI. N Engl J Med. 2009;360:2026-2027.
  11. 11. Vranckx P, Cutlip DE, Mc Fadden EP, Kern MJ, Mahran R, Muller O. Coronary pressure derived fractional flow reserve measurements: recommendations for standardization, recording and reporting as a core laboratory technique. Proposal for integration in clinical trials. Circ Cardiovasc Interv. 2012;5:312-317.10.1161/CIRCINTERVENTIONS.112.96851122511740
  12. 12. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenosis in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816-2821.10.1016/j.jacc.2009.11.09620579537
  13. 13. Lilly LS, Harvard Medical School. Pathophysiology of heart disease: a collaborative project of medical students and faculty. 5th ed. Baltimore/MD: Wolters Kluwer Lippincott Williams & Wilkins; 2011.
  14. 14. Leonardi RA, Townsend JC, Patel CA, et al. Left ventricular end-diastolic pressure affects measurement of fractional flow reserve. Cardiovasc Revasc Med. 2013;14:218-222.10.1016/j.carrev.2013.06.001376000623886870
  15. 15. De Bruyne B, Piljs NH, Kalesan B, et al. Fractional flow reserve – guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2009;360:213-224.10.1056/NEJMoa080761119144937
  16. 16. De Bruyne B, Piljs NH, Barbato E, et al. Intracoronary and intravenous adenosine 5-triphosphate, adenosine, papaverine and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877-1883.10.1161/01.CIR.0000061950.24940.8812668522
  17. 17. Yong AS, Daniels D, De Bruyne B, et al. Fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses. Circ Cardiovasc Interv. 2013;6:161-165.10.1161/CIRCINTERVENTIONS.112.00010423549643
  18. 18. Bech GJ, de Bruyne B, Piljs NH, et al. Fractional flow reserve to determine the appropiatenes of angioplasty in moderate coronary stenosis; a randomized trial. Circulation. 2001;103:2928-2934.10.1161/01.CIR.103.24.2928
  19. 19. De Bruyne B, Piljs NH, Bartunek J, et al. Fraxctional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157-162.10.1161/01.CIR.104.2.157
  20. 20. Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561-569.10.1253/circj.CJ-13-0161
  21. 21. Van Belle E, Rioufol G, Pouillot C, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129:173-185.10.1161/CIRCULATIONAHA.113.00664624255062
  22. 22. Melikian N, Cuisset T, Hamilos M, De Bruyne B. Fractional flow reserve – the influence of the collateral circulation. Int J Cardiol. 2009;132:e109-e110.10.1016/j.ijcard.2007.08.03418055036
  23. 23. Wijns W, Kohl P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501-2555.10.1093/eurheartj/ehq27720802248
  24. 24. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side branch intervention strategy for bifurcation lesion using fractional flow reserve. Eur Heart J. 2008;29:726-732.10.1093/eurheartj/ehn04518308689
  25. 25. Koo BK. Physiologic evaluation of bifurcation lesions using fractional flow reserve. J Interv Cardiol. 2009;22:110-113.10.1111/j.1540-8183.2009.00437.x19379467
  26. 26. Fearon WF, Shilane D, Piljs NH, et al. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation. 2013;128:1335-1340.10.1161/CIRCULATIONAHA.113.00305923946263
  27. 27. Ntalianis A, Sles JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274-1281.10.1016/j.jcin.2010.08.02521232721
  28. 28. Levine GN, Bates ER, Blankenship, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ant the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651.10.1161/CIR.0b013e31823a559622064598
  29. 29. Fearon WF. Percutaneous Coronary Intervention Should Be Guided by Fractional Flow reserve Measurement. Circulation. 2014;129:1860-1870.10.1161/CIRCULATIONAHA.113.004300554493724799502
  30. 30. Burzotta F, Leone AM, De Maria GL, et al. Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial. Trials. 2014;15:140.10.1186/1745-6215-15-140400135424758510
  31. 31. Meuwissen M, Chamuleau SA, Siebes M, et al. Role of variability in microvascular resistence on fractional flow reserve and coronary blood velocity reserve in intermediate coronary lesions. Circulation. 2001;103:184-187.10.1161/01.CIR.103.2.18411208673
  32. 32. Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59:1392-1402.10.1016/j.jacc.2011.11.00322154731
  33. 33. Berry C, van t Veer M, Witt N, et al. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61:1421-1427.10.1016/j.jacc.2012.09.06523395076
  34. 34. Escaned J, Echavarria-Pinto M, Garcia-Garcia HM, et al. Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADIVSE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). JACC Cardiovasc Interv. 2015;8:824-833.10.1016/j.jcin.2015.01.02925999106
  35. 35. Nijjer SS, Sen S, Petraco R, et al. Pre-angioplasty instantaneous wave-free ratio pullback provides virtual intervention and predicts hemodynamic outcome for serial lesions and diffuse coronary artery disease. JACC Cardiovasc Interv. 2014;7:1386-1396.10.1016/j.jcin.2014.06.01525459526
  36. 36. Van Belle E. DEFINE REAL: a prospective, observational, non-randomised, European, multicentre registry, collecting real-life information for the utilisation of iFR in assessing coronary stenosis relevance in the multivessel disease patient population. Presented at: EuroPCR 2016.
  37. 37. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235.10.1056/NEJMoa100235821247313
  38. 38. Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future? J Am Coll Cardiol. 2016;67:2772-2788.
  39. 39. Nijjer SS, Sen S, Petraco R, et al. Improvement in coronary haemodynamics after percutaneous coronary intervention: assessment using instantaneous wave-free ratio. Heart. 2013;99:1740-174810.1136/heartjnl-2013-304387384176224047640
  40. 40. Fearon WF, Aarnoudse W, Pijls NH, et al. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation. 2004;109:2269-2272.10.1161/01.CIR.0000128669.99355.CB15136503
  41. 41. De Bruyne B, Barbato E. Quantitative assessment of the coronary microvasculature: new tools for the black box. Circulation. 2013;127:2378-2379.10.1161/CIRCULATIONAHA.113.00336123681065
  42. 42. Fearon WF, Low AF, Yong AS, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436-2441.10.1161/CIRCULATIONAHA.112.000298542986423681066
DOI: https://doi.org/10.1515/jim-2016-0073 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 231 - 236
Submitted on: Oct 4, 2016
Accepted on: Nov 2, 2016
Published on: Dec 29, 2016
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Monica Chiţu, Nora Rat, Diana Opincariu, Alexandra Stănescu, András Mester, Theodora Benedek, Imre Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.